The diagnosis and treatment of primary dysmenorrhea

In: Journal of Education, Health and Sport · 2022 · vol. 12(9) , pp. 632–638 · doi:10.12775/jehs.2022.12.09.076 · W4295027754
article OA: diamond CC0
AI-generated summary by claude@2026-07, 2026-07-09

Primary dysmenorrhea, characterized by pelvic pain due to endometrial prostaglandin overproduction, is common and treatable with hormonal contraception, NSAIDs, or alternative therapies when conventional treatment is contraindicated.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text

The paper reviews the diagnosis and treatment of primary dysmenorrhea, a common cause of pelvic pain in adolescent girls and reproductive-age women, defining it as menstrual-cycle–related pelvic pain without a specific underlying cause. It describes a key mechanistic model centered on endometrial overproduction of prostaglandins leading to uterine hypercontractility, ischemia/hypoxia, and pain, and summarizes that hormonal contraception and NSAIDs are effective, while typical histories can support empirical therapy without further testing, with the important caveat that secondary causes must be excluded. It also outlines less common alternatives when conventional options are contraindicated (e.g., heat, TENS, lifestyle changes, dietary supplements, acupuncture/acupressure) and notes that surgical approaches are rare and reserved for severe, treatment-resistant cases. Relevance to endometriosis: the paper discusses dysmenorrhea and explicitly emphasizes excluding secondary causes, within the context of broader gynecologic pelvic-pain differentials that include endometriosis (citing ACOG Committee Opinion No. 760 on dysmenorrhea and endometriosis in adolescents), though the paper’s main focus is primary dysmenorrhea management rather than endometriosis itself.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Primary dysmenorrhea is defined as pain in the pelvic area that occurs for no specific reason during menstrual cycle. Dysmenorrhea occurs in 50% to 90% of adolescent girls and women of reproductive age which makes it one of the most common causes of pelvic pain in women. The mechanism of this condition is overproduction of prostaglandins by the endometrium, causing uterine hypercontractility, thereby leading to uterine muscle ischemia, hypoxia and pain. Dysmenorrhea significantly reduces the quality of women life, often making it impossible to perform daily activities and, in addition, it may cause a mental stress that makes both professional and school life difficult. Despite this, females often consider these symptoms as a normal part of their menstrual cycle, which makes this disease underrated and untreated. Dysmenorrhea can be treated in a various ways such as non-pharmacological, pharmacological and surgical. However, women with a typical history of primary dysmenorrhea can commence empirical therapy without any additional tests. Hormonal contraception and nonsteroidal antiinflammatory drugs have proved to be effective in this treatment. However, if conventional treatment is contraindicated, alternative treatments such as topical heat, lifestyle modification, transcutaneous electrical nerve stimulation, dietary supplements, acupuncture, and acupressure may be used. Surgical treatment is possible, but it is used rarely and only in severe cases of treatment-resistant dysmenorrhea. However, it should be emphasized how important it is to exclude secondary causes of dysmenorrhea.
Full text 4,902 characters · extracted from oa-doi-fallback · click to expand
The diagnosis and treatment of primary dysmenorrhea DOI: https://doi.org/10.12775/JEHS.2022.12.09.076Keywords primary dysmenorrhea, dysmenorrhea, menstruationAbstract Primary dysmenorrhea is defined as pain in the pelvic area that occurs for no specific reason during menstrual cycle. Dysmenorrhea occurs in 50% to 90% of adolescent girls and women of reproductive age which makes it one of the most common causes of pelvic pain in women. The mechanism of this condition is overproduction of prostaglandins by the endometrium, causing uterine hypercontractility, thereby leading to uterine muscle ischemia, hypoxia and pain. Dysmenorrhea significantly reduces the quality of women life, often making it impossible to perform daily activities and, in addition, it may cause a mental stress that makes both professional and school life difficult. Despite this, females often consider these symptoms as a normal part of their menstrual cycle, which makes this disease underrated and untreated. Dysmenorrhea can be treated in a various ways such as non-pharmacological, pharmacological and surgical. However, women with a typical history of primary dysmenorrhea can commence empirical therapy without any additional tests. Hormonal contraception and nonsteroidal antiinflammatory drugs have proved to be effective in this treatment. However, if conventional treatment is contraindicated, alternative treatments such as topical heat, lifestyle modification, transcutaneous electrical nerve stimulation, dietary supplements, acupuncture, and acupressure may be used. Surgical treatment is possible, but it is used rarely and only in severe cases of treatment-resistant dysmenorrhea. However, it should be emphasized how important it is to exclude secondary causes of dysmenorrhea. References Dawood, M Yusoff MD. Primary Dysmenorrhea: Advances in Pathogenesis and Management. Obstetrics & Gynecology: August 2006 - Volume 108 - Issue 2 - p 428-441 doi: 10.1097/01.AOG.0000230214.26638.0c Stella Iacovides, Ingrid Avidon, Fiona C. Baker, What we know about primary dysmenorrhea today: a critical review, Human Reproduction Update, Volume 21, Issue 6, November/December 2015, Pages 762–778, https://doi.org/10.1093/humupd/dmv039 Burnett M, Lemyre M. No. 345-primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can 2017; 39 (07) 585-595 . Doi: 10.1016/j.jogc.2016.12.023 Burnett MA, Antao V, Black A, Feldman K, Grenville A, Lea R, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can 2005;27:765–70. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update 2015; 21 (06) 762-778 . Doi: 10.1093/humupd/dmv039 Guimarães I, Póvoa AM. Primary Dysmenorrhea: Assessment and Treatment. Rev Bras Ginecol Obstet. 2020 Aug;42(8):501-507. English. doi: 10.1055/s-0040-1712131. Epub 2020 Jun 19. PMID: 32559803. Osayande AS, Mehulic S. Diagnosis and initial management of dysmenorrhea. Am Fam Physician. 2014 Mar 1;89(5):341-6. PMID: 24695505. Ferries-Rowe, Elizabeth MD, MA; Corey, Elizabeth MD, MPH; Archer, Johanna S. VMD, MD. Primary Dysmenorrhea: Diagnosis and Therapy. Obstetrics & Gynecology: November 2020 - Volume 136 - Issue 5 - p 1047-1058 doi: 10.1097/AOG.0000000000004096 Morrow C, Naumburg EH. Dysmenorrhea. Prim Care 2009; 36 (01) 19-32, vii . Doi: 10.1016/j.pop.2008.10.004 Coco AS. Primary dysmenorrhea. Am Fam Physician. 1999 Aug;60(2):489-96. PMID: 10465224. Ryan SA. The treatment of dysmenorrhea. Pediatr Clin North Am 2017; 64 (02) 331-342 . Doi: 10.1016/j.pcl.2016.11.004 ACOG Committee Opinion No. 760: dysmenorrhea and endometriosis in the adolescent. Obstet Gynecol 2018; 132 (06) e249-e258 . Doi: 10.1097/AOG.0000000000002978 Smith RP, Kaunitz AM. Dysmenorrhea in adult women: treatment [Internet]. 2019 [cited 2019 Mar 10]. Available from: https://www.uptodate.com/contents/dysmenorrhea-in-adult-women-treatment Doty E, Attaran M. Managing primary dysmenorrhea. J Pediatr Adolesc Gynecol 2006; 19 (05) 341-344 . Doi: 10.1016/j.jpag.2006.06.005 Ramirez C, Donnellan N. Pelvic denervation procedures for dysmenorrhea. Curr Opin Obstet Gynecol 2017; 29 (04) 225-230 . Doi: 10.1097/GCO.0000000000000379 French L. Dysmenorrhea. Am Fam Physician 2005; 71 (02) 285-291 Downloads Published How to Cite Issue Section License Copyright (c) 2022 Karolina Obuchowska, Aleksandra Obuchowska, Arkadiusz Standyło, Kamila Gorczyca, Justyna Wójcik-Grudzień, Alicja Ozga-Stachurska, Paulina Pawłowska, Martyna Rozenbajgier, Przemysław Żelazny, Joanna Filipczak, Żaneta Kimber-Trojnar, Bożena Leszczyńska-Gorzelak This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Stats Number of views and downloads: 2196 Number of citations: 0

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

dysmenorrhea

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (13)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK